Form 4 for CYRX Cryoport, Inc.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-15 · accession 0001104659-23-033874 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | CYRX | BADDOUR LINDA | Dir | M - OptEx | $0.00 | +1,111 | 12.5K | +10% | $0 |
| D | 2023-03-17 | 2023-03-15 | CYRX | BADDOUR LINDA | Dir | M - OptEx | $0.00 | -1,111 | 1,111 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | M | A | 1,111 | $0.00 | 12,474 | D | — | — | (F1) Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. |
| 2 | Derivative | Restricted Stock Rights | 2023-03-15 | M | D | 1,111 | $0.00 | 1,111 | D | — · — to — | 1,111 Common Stock | (F2) The originally granted restricted stock rights vest in three equal annual installments beginning March 15, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 15, 2023. |